RoundTable Healthcare Partners

RoundTable Healthcare Partners is a private equity firm based in Lake Forest, Illinois, founded in 2001. The firm specializes in providing equity and debt financing primarily within the healthcare sector, focusing on middle-market investments. Its investment strategy includes buyouts, going-private transactions, platform acquisitions, and consolidation investments, targeting underperforming businesses and strategic assets. RoundTable Healthcare Partners manages several funds that invest in various healthcare-related areas such as medical devices, pharmaceuticals, biotechnology, and consumer health products. The firm does not engage in startup or venture capital investments, instead concentrating on established companies within the healthcare industry that require operational improvements or strategic repositioning. Through its expertise and targeted investments, RoundTable aims to enhance value and foster growth in its portfolio companies.

Fouad Abou-Chakra

Senior Vice President, Manufacturing

Richard C. Adloff

Operating Partner

Michelle An

Associate

Billy Barth

Senior Associate

Connor Brown

Senior Associate

Sue Cho

Vice President, Controller

R. Craig Collister

Managing Partner and Member of the Management Committee

Timothy Connors

Managing Partner

James Dorman

Vice President

Patrick Healy

Vice President

Andrew B. Hochman

Managing Partner

Todd Hutsko

Senior Vice President

Thomas Kapfer

Managing Partner

John McConachie Jr.

Senior Vice President, Health Systems

Isaac Schmitz

Associate

Phillip Smith II

Partner

8 past transactions

DDS Lab

Acquisition in 2021
DDS Lab LLC operates as a dental laboratory in the United States. The company provides dental services with fixed and removable products, such as crown and bridge, dentures, partials, implants, orthodontics, Fierce mouth guards, and CAD/CAM restorations. It provides intraoral scanners and digital impression facilities and consultations. The company also offers online dentistry courses. DDS Lab LLC has a strategic alliance with Keystone Dental. The company was founded in 2005 and is based in Tampa, Florida. It has locations in El Segundo, California; and Dallas, Texas.

Deerland Enzymes, Inc.

Venture Round in 2017
Deerland Enzymes, Inc. is a prominent specialty formulator and contract manufacturer focusing on enzyme-based dietary supplements. The company offers a range of services, including the development of probiotic, prebiotic, and enzyme-based ingredients aimed at enhancing microbiome health. With a team of industry experts operating from a state-of-the-art laboratory, Deerland collaborates closely with clients from the initial concept stage through product design and final formulation. This partnership ensures a comprehensive understanding of customer goals, allowing for tailored solutions that meet specific needs. In addition to product development, Deerland provides regulatory support and specialty manufacturing services, which encompass bulk blends, liquids, hard shell capsules, tablets, as well as bottling and labeling.

Revision Skincare

Funding Round in 2016
For over 25 years, Revision Skincare has provided physicians with clinically proven, high-performing skincare products. Using only the purest, most efficacious ingredients, the Revision Skincare collection was formulated to provide targeted solutions for enhancing skin’s appearance and reducing signs of aging. Revision Skincare products represent the furthest advancements in scientific skincare. Our formulations are rooted in rigorous research and testing, and manufactured by us using the highest ethical standards. Revision Skincare products are never tested on animals.

Goodier Cosmetics

Funding Round in 2016
Goodier Cosmetics is a Dallas, Texas-based manufacturer specializing in perfumes, cosmetics, and other personal care products. The company operates from over 110,000 square feet of warehouse and manufacturing space, focusing on product development and formulation with an emphasis on innovative technologies. Goodier Cosmetics serves a diverse clientele, including entrepreneurs and established companies, by providing expert formulation, large-scale filling, and manufacturing services. The company is known for producing some of the most recognized skin care products on the market while maintaining strict confidentiality regarding its clients. Committed to quality, Goodier Cosmetics operates a facility that is compliant with current Good Manufacturing Practices (cGMP), is registered with the FDA, and holds an over-the-counter (OTC) manufacturing license.

Symmetry Surgical

Acquisition in 2016
Symmetry Surgical Inc. (“Symmetry”) owns and operates the www.Symmetrysurgical.com website (the "Site"), which is hosted in the United States. This Privacy Policy (the “Policy”) is intended to ensure you understand how we collect and use data about your visit to this Site. To that end, below is a summary of the information the Site collects and how it is used. For sales and support purposes, the Site collects some personally identifiable information (“PII”), which could include your name, address, email address, telephone or fax number, IP address and certain other information. We also use cookies, which gather certain forms of information from your computer to help us monitor and improve Site usage and performance. You can choose not to provide us with this information, but if you make this election then certain portions of the Site may not be available for your use.

TIDI Products

Acquisition in 2015
TIDI Products, headquartered in Neenah, WI, is a premier designer, developer, and manufacturer of medical devices focused on preventing infections and supporting caregivers across the acute care, alternate site and dental end-markets. The Company offers a broad portfolio of over 4,400 SKUs of Class I and Class II medical devices and serves more than 3,000 customers around the world via a combination of direct sales, OEMs and distribution partners. The Company maintains global manufacturing facilities that include two FDA registered U.S. facilities, one FDA registered Chinese facility and one U.S. distribution center.

Bioniche Pharma Group

Acquisition in 2005
Bioniche Pharma Group manufactures and markets sterile injectable pharmaceutical products.

CorePharma

Acquisition in 2005
CorePharma, founded in 1998, is a developer, manufacturer and marketer of high-quality, targeted, generic prescription pharmaceuticals across a variety of dosage forms and therapeutic categories. We specialize in difficult-to-develop high value products across a variety of therapeutic areas and currently produce almost one-half billion tablets and capsules annually. Our expertise in product development and manufacturing is complemented by robust sales, marketing and distribution capabilities.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.